Lapatiniblet and mucosal inflammation Patient Reports February 10, 2010

Lapatiniblet Side Effects Report #5644108-1
Lapatiniblet side effect was reported by a Physician from CHINA on Feb 13, 2008. Male patient, 48 years of age, weighting 145.2 lb, was diagnosed with squamous cell carcinoma and was treated with Lapatiniblet. After drug was administered, patient experienced the following side effects: mucosal inflammation. Lapatiniblet dosage: 1500 MG/PER DAY/ORAL. During the same period patient was treated with CISPLATIN. Patient recovered.

Lapatiniblet Side Effects Report #5644088-9
Lapatiniblet side effect was reported by a Physician from SPAIN on Feb 13, 2008. Female patient, 53 years of age, weighting 358.9 lb, was diagnosed with breast cancer metastatic and was treated with Lapatiniblet. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood potassium decreased, blood urea increased, diarrhoea, lymphocyte count decreased, mucosal inflammation, neutrophil count increased. Lapatiniblet dosage: 1250 MG/PER DAY/ORAL. During the same period patient was treated with CAPECITABINELET. Patient was hospitalized. Patient recovered.